Scientists from the Department of Defense and the National Institutes of Health urged biotechnology and pharmaceutical companies to develop treatments for biowarfare agents at an industry meeting on Tuesday, indicating the government is stepping up efforts to ensure it is prepared for bioterrorist attacks. Full Story